Stenotrophomonas Bacteremia Antibiotic Susceptibility and Prognostic Determinants: Mayo Clinic 10-Year Experience.

Ahmed M HamdiMadiha FidaOmar M Abu SalehElena Beam

Published in: Open forum infectious diseases (2020)

Although TMP-SMX continues to have reliable activity in our cohort, we noted resistance to TMP-SMX in patients with recent TMP-SMX exposure, including a case with developing resistance to TMP-SMX while on therapy.

Keyphrases

stem cells
bone marrow
cell therapy